These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 27872156)

  • 1. Association Between Blood Pressure and Adverse Renal Events in Type 1 Diabetes.
    Ku E; McCulloch CE; Mauer M; Gitelman SE; Grimes BA; Hsu CY
    Diabetes Care; 2016 Dec; 39(12):2218-2224. PubMed ID: 27872156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kidney disease and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.
    de Boer IH;
    Diabetes Care; 2014; 37(1):24-30. PubMed ID: 24356594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistant Hypertension, Time-Updated Blood Pressure Values and Renal Outcome in Type 2 Diabetes Mellitus.
    Viazzi F; Piscitelli P; Ceriello A; Fioretto P; Giorda C; Guida P; Russo G; De Cosmo S; Pontremoli R;
    J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28939716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort.
    de Boer IH; Rue TC; Cleary PA; Lachin JM; Molitch ME; Steffes MW; Sun W; Zinman B; Brunzell JD; ; White NH; Danis RP; Davis MD; Hainsworth D; Hubbard LD; Nathan DM
    Arch Intern Med; 2011 Mar; 171(5):412-20. PubMed ID: 21403038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Effects of Intensive Glycemic and Blood Pressure Control and Fenofibrate Use on Kidney Outcomes.
    Mottl AK; Buse JB; Ismail-Beigi F; Sigal RJ; Pedley CF; Papademetriou V; Simmons DL; Katz L; Mychaleckyj JC; Craven TE
    Clin J Am Soc Nephrol; 2018 Nov; 13(11):1693-1702. PubMed ID: 30361335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and progression of renal insufficiency with and without albuminuria in adults with type 1 diabetes in the diabetes control and complications trial and the epidemiology of diabetes interventions and complications study.
    Molitch ME; Steffes M; Sun W; Rutledge B; Cleary P; de Boer IH; Zinman B; Lachin J;
    Diabetes Care; 2010 Jul; 33(7):1536-43. PubMed ID: 20413518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Annual deterioration of renal function in hypertensive patients with and without diabetes.
    Polonia J; Azevedo A; Monte M; Silva JA; Bertoquini S
    Vasc Health Risk Manag; 2017; 13():231-237. PubMed ID: 28721063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved home BP profile with dapagliflozin is associated with amelioration of albuminuria in Japanese patients with diabetic nephropathy: the Yokohama add-on inhibitory efficacy of dapagliflozin on albuminuria in Japanese patients with type 2 diabetes study (Y-AIDA study).
    Kinguchi S; Wakui H; Ito Y; Kondo Y; Azushima K; Osada U; Yamakawa T; Iwamoto T; Yutoh J; Misumi T; Aoki K; Yasuda G; Yoshii T; Yamada T; Ono S; Shibasaki-Kurita T; Hosokawa S; Orime K; Hanaoka M; Sasaki H; Inazumi K; Yamada T; Kobayashi R; Ohki K; Haruhara K; Kobayashi Y; Yamanaka T; Terauchi Y; Tamura K
    Cardiovasc Diabetol; 2019 Aug; 18(1):110. PubMed ID: 31455298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood pressure and pulse pressure effects on renal outcomes in the Veterans Affairs Diabetes Trial (VADT).
    Anderson RJ; Bahn GD; Emanuele NV; Marks JB; Duckworth WC;
    Diabetes Care; 2014 Oct; 37(10):2782-8. PubMed ID: 25048382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prevalence of chronic kidney disease in Finnish patients with type 2 diabetes treated in primary care.
    Metsärinne K; Bröijersen A; Kantola I; Niskanen L; Rissanen A; Appelroth T; Pöntynen N; Poussa T; Koivisto V; Virkamäki A;
    Prim Care Diabetes; 2015 Feb; 9(1):31-8. PubMed ID: 25066820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Blood Pressure With the Progression of CKD: Findings From KNOW-CKD Study.
    Lee JY; Park JT; Joo YS; Lee C; Yun HR; Yoo TH; Kang SW; Choi KH; Ahn C; Oh KH; Sung S; Kim SW; Lee J; Han SH;
    Am J Kidney Dis; 2021 Aug; 78(2):236-245. PubMed ID: 33444666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient and disease characteristics of type-2 diabetes patients with or without chronic kidney disease: an analysis of the German DPV and DIVE databases.
    Bramlage P; Lanzinger S; van Mark G; Hess E; Fahrner S; Heyer CHJ; Friebe M; Seufert J; Danne T; Holl RW
    Cardiovasc Diabetol; 2019 Mar; 18(1):33. PubMed ID: 30878037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of intensive diabetes treatment on albuminuria in type 1 diabetes: long-term follow-up of the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications study.
    DCCT/EDIC research group
    Lancet Diabetes Endocrinol; 2014 Oct; 2(10):793-800. PubMed ID: 25043685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SGLT2 Inhibitors and the Diabetic Kidney.
    Fioretto P; Zambon A; Rossato M; Busetto L; Vettor R
    Diabetes Care; 2016 Aug; 39 Suppl 2():S165-71. PubMed ID: 27440829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal outcomes in patients with type 1 diabetes and macroalbuminuria.
    de Boer IH; Afkarian M; Rue TC; Cleary PA; Lachin JM; Molitch ME; Steffes MW; Sun W; Zinman B;
    J Am Soc Nephrol; 2014 Oct; 25(10):2342-50. PubMed ID: 24925722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Albuminuria Changes and Cardiovascular and Renal Outcomes in Type 1 Diabetes: The DCCT/EDIC Study.
    de Boer IH; Gao X; Cleary PA; Bebu I; Lachin JM; Molitch ME; Orchard T; Paterson AD; Perkins BA; Steffes MW; Zinman B;
    Clin J Am Soc Nephrol; 2016 Nov; 11(11):1969-1977. PubMed ID: 27797889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adiponectin is associated with early diabetic kidney disease in adults with type 1 diabetes: A Coronary Artery Calcification in Type 1 Diabetes (CACTI) Study.
    Bjornstad P; Pyle L; Kinney GL; Rewers M; Johnson RJ; Maahs DM; Snell-Bergeon JK
    J Diabetes Complications; 2017 Feb; 31(2):369-374. PubMed ID: 27368123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study.
    Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group
    JAMA; 2003 Oct; 290(16):2159-67. PubMed ID: 14570951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk Factors for Kidney Disease in Type 1 Diabetes.
    Perkins BA; Bebu I; de Boer IH; Molitch M; Tamborlane W; Lorenzi G; Herman W; White NH; Pop-Busui R; Paterson AD; Orchard T; Cowie C; Lachin JM;
    Diabetes Care; 2019 May; 42(5):883-890. PubMed ID: 30833370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Time-Varying Blood Pressure With Chronic Kidney Disease Progression in Children.
    Reynolds BC; Roem JL; Ng DKS; Matsuda-Abedini M; Flynn JT; Furth SL; Warady BA; Parekh RS
    JAMA Netw Open; 2020 Feb; 3(2):e1921213. PubMed ID: 32058554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.